CEO SUMMARY: Although the field of pharmacogenomics is still in its infancy, it has begun to develop sub-specialty areas. “Companion diagnostics” describes the marriage of a therapeutic drug with a specific diagnostic assay that can identify which patients will benefit from a prescription and which will not. “Companion diagnostics” will generally have reasonable reimbursement for […]
“Companion Diagnostics” Enter Lab Marketplace
Expected to be good for diagnostic vendors, but mixed benefits for clin labs and drug firms
- By Robert Michel
- > From the Volume X No. 8 - June 16, 2003 Issue